Indian biotech start-ups attract $2.8 bn in investments in last 5 years

Of the 3,000 entrepreneurs who've started biotech firms in the past 5 years, a third are women

biotech, lab,
Photo: Shutterstock
Alnoor Peermohamed Bengaluru
Last Updated : Feb 10 2017 | 6:17 PM IST
India has over 3,000 entrepreneurs, one third of whom are women, who have started biotechnology firms in the past five years and have raised a combined total of $2.8 billion or Rs 18,700 crore in the same period.

These entrepreneurs have formed 1,022 biotechnology start-ups in the period between 2012 and 2016, with the major hubs for firms being Bengaluru, Delhi, Mumbai and Hyderabad, according to a report from the Association of Biotechnology Led Enterprises (ABLE).

The numbers are promising for the biotechnology sector in India, which had identified start-ups as a key driver for growth as early as 2012. With over 470 biotech start-ups being formed in the last two years alone, the possibility of reaching a goal of 2,000 biotechnology startups by 2020 seems possible.

ABLE found that of these 1,022 start-ups 57 per cent of them were working in the field of Bio-pharma, 16 per cent in Bio-research services, 10 per cent in Bio-agri and 9 per cent in Bio-industrial sectors. The report also says that most biotech startups in the country have adopted a combination of products and services offerings.

"While bulk of the start-ups have been working with basic biochemical processes, the R&D kind of start-ups are on the rise too. Nearly 16 percent of the start-ups have showed their activity as research and experimental development," the report said.

With the help of government policy at both a centre and state level along with funds for biotech startups, entrepreneurs in India have begun giving the biotech space a harder look. The ABLE report paints a positive picture for biotechnology in India, with cutting edge research and development being driven out of these new companies.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Next Story